Contents
  • Understanding Carcinoid Syndrome
  • Where Does It Happen?
  • What Are the Symptoms?

What is Carcinoid Syndrome and Why Should You Care?

What is Carcinoid Syndrome and Why Should You Care?

The Big Picture

Carcinoid syndrome is a complex set of symptoms caused by certain types of tumors. Understanding its features is crucial for early detection and management.
Contents
  • Understanding Carcinoid Syndrome
  • Where Does It Happen?
  • What Are the Symptoms?

Understanding Carcinoid Syndrome

Carcinoid syndrome results from neuroendocrine tumors (NETs) releasing various substances into the body. These tumors are most commonly found in the digestive tract and lungs and can cause a range of symptoms due to their secretions.

Where Does It Happen?

NETs can develop in various parts of the body, but carcinoid syndrome often occurs with liver metastases. The liver usually deactivates tumor products, but when it can't, these products enter the bloodstream, triggering symptoms.
Carcinoid syndrome is a condition resulting from neuroendocrine tumors (NETs) releasing substances causing symptoms in the body, often associated with liver metastases.

What Are the Symptoms?

The hallmark of carcinoid syndrome is episodic flushing, which affects 85% of patients. It can cause redness in the face, neck, and chest, along with a burning sensation, and sometimes blood pressure changes.

FAQs

What causes carcinoid syndrome?

It's caused by tumors releasing hormones into the body.

Where are these tumors commonly found?

They are often found in the digestive tract and lungs.

What is the most common symptom?

Episodic flushing is the most common symptom.

Are liver metastases always present?

Not always, but they are a common trigger for symptoms.

Key Takeaways

Understanding carcinoid syndrome is vital for managing its symptoms effectively.
Get started by discussing carcinoid syndrome with Doctronic today!
Additional References
  1. Feldman JM, Jones RS. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis. Ann Surg 1982; 196:33.
  2. Halperin DM, Shen C, Dasari A, et al. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol 2017; 18:525.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.